Injection timing remains consistent regardless of dose
Patients may experience dehydration or related complications during GLP-1 therapy
CrossRef Stemness CD24 activation promotes hepatocellular carcinoma progression via an immune escape mechanism Yin Cai, Lu-Yin Liu, Xiao-Xiao Xia, Hao Tang, Min Xu, Wen-Li Sai, Deng-Fu Yao, Min Yao World Journal of Gastroenterology .2026;[Epub] CrossRef Effect of statin use on prognostic outcomes in hepatocellular carcinoma following liver surgery: a systematic review and meta-analysis Diski Saisa, Syifa Mustika, Mochamad Fachrureza, Stevanus Christian Surya, Derren Rampengan, Juan Alessandro Jeremis Maruli Nura Lele, Ammar Nojaid, Michael Owen Hogipranata European Journal of Gastroenterology & Hepatology .2026
It acts as an agonist at GLP-1, GIP, and glucagon receptors to suppress appetite, delay gastric emptying, promote insulin release, and break down fats